Date | Time | Source | Headline | Symbol | Company |
08/02/2024 | 7:00AM | Business Wire | Algoma Central Corporation Reports Financial Results for the 2024 Second Quarter | NYSE:ALC | Alcon Inc |
06/24/2024 | 1:00AM | Business Wire | Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance | NYSE:ALC | Alcon Inc |
06/04/2024 | 1:35PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ALC | Alcon Inc |
06/04/2024 | 1:05PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ALC | Alcon Inc |
05/29/2024 | 5:09PM | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NYSE:ALC | Alcon Inc |
05/24/2024 | 2:10PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ALC | Alcon Inc |
05/17/2024 | 12:10PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ALC | Alcon Inc |
05/13/2024 | 4:31PM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:ALC | Alcon Inc |
05/13/2024 | 4:30PM | Business Wire | Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health | NYSE:ALC | Alcon Inc |
05/08/2024 | 4:30PM | Business Wire | Alcon Announces Results of 2024 Annual General Meeting | NYSE:ALC | Alcon Inc |
05/01/2024 | 9:45AM | Business Wire | Algoma Central Corporation Reports Financial Results for the 2024 First Quarter | NYSE:ALC | Alcon Inc |
04/07/2024 | 5:59PM | Business Wire | Alcon Publishes Agenda for 2024 Annual General Meeting | NYSE:ALC | Alcon Inc |
03/12/2024 | 4:30AM | Business Wire | Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India | NYSE:ALC | Alcon Inc |
03/06/2024 | 9:55AM | Business Wire | Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone | NYSE:ALC | Alcon Inc |
03/06/2024 | 9:55AM | Business Wire | Vivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implants | NYSE:ALC | Alcon Inc |
03/06/2024 | 8:00AM | Business Wire | Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone | NYSE:ALC | Alcon Inc |
03/01/2024 | 6:44PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ALC | Alcon Inc |
02/29/2024 | 5:56PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ALC | Alcon Inc |
02/29/2024 | 1:12PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ALC | Alcon Inc |
02/27/2024 | 4:30PM | Business Wire | Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023 | NYSE:ALC | Alcon Inc |
02/26/2024 | 7:00AM | Business Wire | Algoma Central Corporation Reports Financial Results for Fiscal 2023 | NYSE:ALC | Alcon Inc |
02/12/2024 | 4:22PM | Business Wire | Algoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024 | NYSE:ALC | Alcon Inc |
02/01/2024 | 1:04PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:ALC | Alcon Inc |
02/01/2024 | 9:02AM | Business Wire | Alcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytie | NYSE:ALC | Alcon Inc |
01/18/2024 | 8:54AM | Business Wire | Algoma Central Corporation continues to grow product tanker business with the acquisition of two additional vessels | NYSE:ALC | Alcon Inc |
01/10/2024 | 4:12AM | Dow Jones News | Alcon Shares Rise After Dry-Eye Care Drug Shows Promising Results | NYSE:ALC | Alcon Inc |
01/09/2024 | 5:20PM | Dow Jones News | Alcon Reports Results for Dry-Eye-Treatment Trials | NYSE:ALC | Alcon Inc |
01/09/2024 | 4:30PM | Business Wire | Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye | NYSE:ALC | Alcon Inc |
01/09/2024 | 4:30PM | Business Wire | Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye | NYSE:ALC | Alcon Inc |
01/05/2024 | 8:00AM | GlobeNewswire Inc. | Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements | NYSE:ALC | Alcon Inc |